ClinicalTrials.gg
RecruitingNCT06730815Updated Dec 19, 2024

Body Image and Physical Activity of Women with Breast Cancer

An observational study in Breast Cancer Female, Physical Inactivity and Quality of Life, sponsored by University of Pecs. Recruiting at 2 sites in Hungary. Open to female participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-12-19.

Sponsored by University of Pecs · Observational

From the registry’s dates

  • Primary completion was expected by Feb 2025, 1 year 8 months ago, but the record still lists the study as recruiting.
  • Started Sep 2024; still recruiting 2 years 1 month later.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
300
Ages
18 Years to 80 Years
Sex
Female
01

Study summary

The goal of this self-initiated questionnaire-based follow-up clinical trial is to map the body image and physical activity of Hungarian women treated for breast cancer.

The main questions it aims to answer are:

  1. How body image changes during different treatments among women treated for breast cancer?
  2. How is physical activity among Hungarian women treated for breast cancer?
Read the detailed description

The aim of our research is to assess the changes in physical activity and body image of women with breast cancer and the impact of these changes on their quality of life using subjective measures, through cross-sectional research and validation of the Body Image After Breast Cancer questionnaire in Hungarian.

02

Conditions studied

  • Breast Cancer Female
  • Physical Inactivity
  • Quality of Life
  • Body Image

Keywords

  • body image after breast cancer
  • physical activity
  • life quality
03

In context

Sedentary Behavior

367 studies on the registry are indexed under Sedentary Behavior; 165 are open to participants now.

This study's planned enrollment of 300 is above the median of 150 across 51 observational studies indexed under Sedentary Behavior.

Browse Sedentary Behavior studies →

Lead sponsor

University of Pecs is the lead sponsor of 105 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

In the Department of Oncotherapy in the University of Pécs at the Medical School

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult women diagnosis of breast carcinoma

Exclusion criteria

Exclusion Criteria:

  • neuromuscular diseases
  • severe congenital musculoskeletal and other disorders
  • other surgical procedures within 1 year
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
300 participants (estimated)
Patient registry
No

Groups and cohorts

  • Hungarian women treated for breast cancer
06

What researchers measure

Primary outcomes

  1. Body Image After Breast Cancer

    points, Body Image After Breast Cancer scale contains 53 items in the six main subscales of vulnerability (with twelve items on feelings of the susceptibility of the body to cancer), body stigma (with sixteen items on feeling to hide the body), transparency (with six items on concerns about the obviousness of cancer-related changes to appearance), body limitations (with eight items on feeling about competence and ability), body concerns (with six items on satisfaction about body shape and appearance), and arm concerns (with five items on concerns about arm symptoms and appearance). Items are scored on a five-point Likert scale from "Completely agree" to "Completely disagree" for items 1-23 and from "Never' to "Always" for items 24-53. The higher the points, the worse the body image is.

    Time frame: 1 day

  2. Global Physical Activity Questionnaire

    MET-min, Global Physical Activity Questionnaire, GPAQ, 16 questions in 4 topics (assessing work, travel-related and recreational physical activity, and the time of sitting) minimum score: 0 MET-min, maximum score: 15.600 MET-min, the higher the MET-mins, the better the physical activity is.

    Time frame: 1 week

Secondary outcomes

  1. Patient Health Questionnaire-9

    Points, the scale has 9 items, 4 point scale (not at all - nearly every day). The sum score 0-27. Scores less than 5 almost always signified the absence of a depressive disorder; scores of 5 to 9 predominantly represented patients with either no depression or subthreshold (i.e., other) depression; scores of 10 to 14 represented a spectrum of patients; and scores of 15 or greater usually indicated major depression. The higher the points, the higher the depression is.

    Time frame: 2 weeks

  2. Rosenberg Self-Esteem Scale

    Points, 10 items, 0-3 point scales, the sum scale ranges from 0-30. Scores between 15 and 25 are within normal range; scores below 15 suggest low self-esteem. The higher the points, the better the self-esteem is.

    Time frame: 1 day

  3. Quality of life of cancer patients or survivors (EORTC QLQ-C30)

    EORTC QLQ-C30 is a 30-item instrument designed to measure quality of life in all cancer patients. All items scored 1-4 (not at all - to a great extent). The higher the points, the worse the quality of life is.

    Time frame: 1 week

  4. Quality of life of cancer patients or survivors (EORTC QLQ-BR23)

    EORTC QLQ-BR23 is a 23-item instrument designed to measure quality of life in breast cancer patients. All items scored 1-4 (not at all - to a great extent). The higher the points, the worse the quality of life is.

    Time frame: 4 weeks

  5. Body Attitudes Test (BAT)

    Body Attitudes Test (BAT) has 20 items, all 0-5 points scale (never - always), the sum scale has the minimum of 0, the maximum of 100. The higher the value, the worse the body attitude is.

    Time frame: 1 day

07

Study locations

2 of 2 sites recruiting
  • Vörösmarty utca 4.
    Pécs, Baranya 7621, Hungary
    • Márta Hock, physiotherapist · Contact · hock.marta@etk.pte.hu · +3672501500
    • Márta Hock, physiotherapist · Contact
    Recruiting
  • Édesanyák útja 17.
    Pécs, Baranya 7624, Hungary
    • Erika Kövér, physician · Contact · kover.erika@pte.hu · +36-72-536-480
    • Erika Kövér, physician · Contact
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2024 (actual). Primary completion is estimated for Feb 2025, 5 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 8, 2024
First posted
Dec 12, 2024
StartActual
Sep 1, 2024
Primary completionEst.
Feb 2025
CompletionEst.
Aug 31, 2025
Last update
Dec 19, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06730815
Lead sponsor
University of Pecs
Responsible party
Sponsor
First posted
Dec 12, 2024
Start date
Sep 1, 2024
Primary completion
Feb 2025 (estimated)
Completion
Aug 31, 2025 (estimated)
Last update
Dec 19, 2024

Study contacts

Márta Hock, physiotherapist
Contact
hock.marta@etk.pte.hu
+3672501500 ext. 38062
Zsuzsanna Poto, economist
Contact
zsuzsanna.poto@etk.pte.hu
+36205019991

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion